Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N–methyl-D-aspartate (NMDA)

PURPOSE: Glaucoma is a group of chronic optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, and they ultimately cause blindness. Because neuroprotection using neurotrophic factors against RGC loss has been proven a beneficial strategy, extensive att...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiozawa, Asaka Lee, Igarashi, Tsutomu, Kobayashi, Maika, Nakamoto, Kenji, Kameya, Shuhei, Fujishita, Shigeto, Takahashi, Hiroshi, Okada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300199/
https://www.ncbi.nlm.nih.gov/pubmed/32565669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300199/
https://www.ncbi.nlm.nih.gov/pubmed/32565669

Ejemplares similares